Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.80 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.43.8 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.128 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.220NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.257NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.5.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.323NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.15NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.105 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.9 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.398NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.94 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.164NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.275NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.81NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.419NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.151NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
V.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.149NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.413NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.107NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.10 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.41 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AS.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.142NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.166NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.11 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.34.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.50NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.60NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used